Pain, anxiety and insomnia - A global perspective on the relief of suffering: Comparative review

British Journal of Psychiatry

Volumn 183, Issue JULY, 2003, Pages 15-21

  Ghodse, Hamid ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CODEINE; DEXTROPROPOXYPHENE; DIAZEPAM; DIHYDROCODEINE; FENTANYL; HYDROMORPHONE; HYPNOTIC SEDATIVE AGENT; KETOBEMIDONE; METHYLPHENIDATE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE; PETHIDINE; PSYCHOTROPIC AGENT; TILIDINE; TRIMEPERIDINE;

ANXIETY DISORDER; DEVELOPING COUNTRY; DRUG DEPENDENCE; DRUG INDUSTRY; DRUG MISUSE; DRUG UTILIZATION; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HUMAN; INDUSTRIALIZATION; INSOMNIA; PAIN; REVIEW;

ANALGESICS; ANXIETY; DEVELOPING COUNTRIES; DRUG AND NARCOTIC CONTROL; DRUG COSTS; DRUG INDUSTRY; ETHICS, MEDICAL; HEALTH SERVICES ACCESSIBILITY; HUMANS; PSYCHOTROPIC DRUGS; SLEEP INITIATION AND MAINTENANCE DISORDERS; TELEMEDICINE; WORLD HEALTH;

EID: 0037625434     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.183.1.15     Document Type: Review

References (28)

1. Bonica, J. J. (1985) Treatment of cancer pain: current status and future needs. In Advances in Pain Research and Therapy (eds H. L. Field, R. Dubner & F. Cerveo), vol. 9, pp. 589-616. New York: Raven Press.
2. Bjorntorp, P. (1997) Obesity. Lancet, 350, 423-426.
3. Fisch, H. U. (1979) Sociopharmacology: psychoactive drugs as an example. Schweizerische Medizinische Wochenschrift, 109, 461-466.
4. Fombonne, E., Mousson, F., Dassonville, B., et al (1989) A study of prescriptions for psychotropic drugs at a French psychiatric hospital. Revue Epidemologique Santé Publique, 37, 29-36.
5. Ghodse, H. (1999) Dramatic increase in methylphenidate consumption. Current Opinion in Psychiatry, 12, 265-268.
6. _ (2002) Drugs and Addictive Behaviour: A Guide to Treatment (3rd edn). Cambridge: Cambridge University Press.
7. _ & Khan, I. (1988) Psychoactive Drugs: Improving Prescribing Practices. Geneva: World Health Organization.
8. Gureje, O., von Korff, M., Simon, G. E., et al (1998) Persistent pain and well-being: a World Health Organization study in primary care. Journal of the American Medical Association, 280, 147-151.
9. International Narcotics Control Board (2000) Report of the International Narcotics Control Board for 1999 (E/INCB/1999/1). New York: United Nations.
10. _ (2001) Report of the International Narcotics Control Board for 2000 (E/INCB/2000/1). New York: United Nations.
11. _ (2002a) Narcotic Drugs: Estimated World Requirements for 2002; Statistics for 2000 (E/INCB/2001/2). New York: United Nations.
12. _ (2002b) Psychotropic Drugs: Statistics for 2000. Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV (E/INCB/2001/3). New York: United Nations.
13. Joranson, D. E. (1993) Availability of opioids for cancer pain: recent trends, assessment of system barriers, new WHO Guidelines, and the risk of diversion. Journal of Pain and Symptom Management, 8, 353-360.
14. Regier, D. A., Boyd, J. H., Burke, J. D., Jr, et al (1988) One month prevalence of mental disorders in the United States based on 5 epidemiological catchment area sites. Archives of General Psychiatry, 45, 977-986.
15. Rosenbaum, M., Leibel, R. L. & Hirsch, J. (1997) Obesity. New England Journal of Medicine, 337, 396-407.
16. Tohen, M. & Bromet, E. (2000) Psychiatric epidemiology. In Psychiatry: Behavioural Science and Clinical Essentials (eds J. Kay, A. Tasman & J. A. Lieberman), pp. 145-153. Philadelphia, PA: W. B. Saunders.
17. Twycross, R. G. & Lack, S. A. (1984) Oral Morphine in Advanced Cancer. Beaconsfield: Beaconsfield Publishers.
18. United Nations (1971) Convention on Psychotropic Substances 1971. New York: United Nations.
19. _ (1991) The Protection of Persons with Mental Illness and the Improvement of Mental Health Care. UN General Assembly Resolution A/RES46.119. New York: United Nations.
20. Vuckovic, N. & Nichter, M. (1997) Changing patterns of pharmaceutical practice in the United States. Social Science and Medicine, 44, 1285-1302.
21. World Health Assembly (2002) Mental Health: Responding to the Call for Action. Report by the Secretariat A55/18. Geneva: World Health Organization.
22. World Health Organization (1986) Cancer Pain Relief. Geneva: WHO.
23. _ (1993) WHO Expert Committee on Drug Dependence, 28th Report (Technical Report Series 882). Geneva: WHO.
24. _ (1996) Cancer Pain Relief with a Guide to Opiate Availability (2nd edn). Geneva: WHO.
25. _ (1998) The Use of Essential Drugs: Report of a WHO Expert Committee (Technical Report Series 882). Geneva: WHO.
26. _ (2000) Narcotic and Psychotropic Drugs. Achieving Balance in National Opioids Control Policy. Guidelines for Assessment. Geneva: WHO.
27. _ (2001a) The World Health Report 2001. Mental Health: New Understanding, New Hope. Geneva: WHO.
28. _ (2001b) Atlas Country Profiles of Mental Health Resources 2001. Geneva: WHO.